3649 results for «480»
3649 results
Featured cases - TAVI in aortic regurgitation
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of TAVI to address aortic regurgitation. Gain insights into the management of pure native aortic regurgitation in surgically unfit patients, the treatment of aortic regurgitation in patients with left...
Featured research - Aortic valve (Part 10)
26 Nov 2024 – From PCR London Valves 2024
Explore the latest research and insights in the field of aortic valve interventions through this featured research session. Discover cutting-edge studies on topics ranging from one-year outcomes after TAVI in different valve types to the impact of frailty and mobility on post-TAVI outcomes, and much more....
Featured cases - Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of transcatheter edge-to-edge repair (TEER) for the treatment of tricuspid regurgitation. Explore innovative techniques such as the use of the Pascal device in a patient with dextrocardia, the combination...
Featured cases - When the cardiologist meets the surgeon
26 Nov 2024 – From PCR London Valves 2024
Dive into a collection of captivating clinical cases where the cardiologist and surgeon collaborate to tackle complex cardiovascular challenges. From direct vision TAVI implantation during left ventricular assist device surgery to managing iatrogenic annulus rupture during TAVR, this session offers invaluable insights into the art of...
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease
02 Nov 2022
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...
Author
